Samya Sen

About

Dr. Samya Sen is a microbiologist with a strong academic and research background. He currently serves as an Assistant Professor at Techno India University, West Bengal. He holds a PhD in Microbiology from the University of Kalyani, where his research focused on bacterial diversity, antibiotic resistance, and nanotechnology-based antimicrobial strategies. He completed his postdoctoral research at the Indian Institute of Technology, Jodhpur (IITJ), working on antibacterial peptides, antibiotic adjuvants, and small molecules with therapeutic potential. His research interests encompass antimicrobial nanotechnology, drug design, hydrogels as therapeutic agents, and the gut-brain axis. Over the years, he has contributed to numerous high-impact publications and has filed multiple patents, demonstrating his commitment to innovation in microbiology and biotechnology. Additionally, he has industry experience as a Senior Microbiologist at Lila Agrotech Private Limited, where he applied his expertise to practical, real-world challenges in microbial technology.

Employment

• Techno India University Assistant Professor
  2025 - Present
• iHUB Drishti Foundation, IIT Jodhpur Research Associate
  2023 - 2025
• Indian Institute of Technology Jodhpur Research Associate
  2022 - 2022
• University of Kalyani Postdoctoral Researcher
  2021 - 2022
• Lila Agrotech Pvt Ltd Senior Microbiologist
  2020 - 2021

Education

• Saint Xaviers College Master of Science
  2011 - 2013
• Rastraguru Surendranath College, Barrackpore B.Sc. (Honors) in Microbiology
  2008 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (25)

• Thiophene‐Engineered Lipid II Recognition Enables Potent Membranolytic Eradication of MRSA
  Angewandte Chemie International Edition 2026 DOI: 10.1002/anie.5919230
  +Save
• Thiophene‐Engineered Lipid II Recognition Enables Potent Membranolytic Eradication of MRSA
  Angewandte Chemie 2026 DOI: 10.1002/ange.5919230
  +Save
• Antimicrobial Peptides and Biofilms: From Molecular Interactions to Therapeutic Control
  ACS Infectious Diseases 2026 DOI: 10.1021/acsinfecdis.6c00118
  +Save
• Emergence of an unconventional Enterobacter cloacae-derived Iturin A C-15 as a potential therapeutic agent against methicillin-resistant Staphylococcus aureus
  Archives of Microbiology 2025 DOI: 10.1007/S00203-024-04226-7
  +Save
• Gelatinase-Responsive Short Peptide Conjugate as a Precision Therapy Against Methicillin-Resistant Staphylococcus aureus
  Journal of the American Chemical Society 2025 DOI: 10.1021/JACS.5C11249
  +Save
• Extracellular Matrix Mimicking Wound Microenvironment Responsive Amyloid–Heparin@TAAgNP Co-Assembled Hydrogel: An Effective Conductive Antibacterial Wound Healing Material
  ACS Applied Materials & Interfaces 2024 DOI: 10.1021/acsami.4c05559
  +Save
• Discovery of Quinazoline and Quinoline-Based Small Molecules as Utrophin Upregulators via AhR Antagonism for the Treatment of Duchenne Muscular Dystrophy
  Journal of Medicinal Chemistry 2024 DOI: 10.1021/ACS.JMEDCHEM.4C00398
  +Save
• Multi-Faceted Antimicrobial Efficacy of a Quinoline-Derived Bidentate Copper(II) Ligand Complex and Its Hydrogel Encapsulated Formulation in Methicillin-Resistant Staphylococcus aureus Inhibition and Wound Management
  ACS Applied Bio Materials 2024 DOI: 10.1021/ACSABM.4C00466
  +Save
• Next generation antimitotic β-carboline derivatives modulate microtubule dynamics and downregulate NF-κB, κ B, ERK 1/2 and phospho HSP 27
  Life Sciences 2024 DOI: 10.1016/J.LFS.2024.122836
  +Save
• Synergistic Augmentation of Beta-Lactams: Exploring Quinoline-Derived Amphipathic Small Molecules as Antimicrobial Potentiators against Methicillin-Resistant Staphylococcus aureus
  ACS Infectious Diseases 2024 DOI: 10.1021/ACSINFECDIS.3C00696
  +Save